Inhibition of phosphatidylinositol 3′-kinase induces preferentially killing of PTEN-null T leukemias through AKT pathway
- 30 July 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 320 (3) , 932-938
- https://doi.org/10.1016/j.bbrc.2004.06.038
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002
- Rational therapeutic intervention in cancer: kinases as drug targetsCurrent Opinion in Genetics & Development, 2002
- The rapamycin-sensitive signal transduction pathway as a target for cancer therapyOncogene, 2000
- Loss of PTEN expression leading to high Akt activation in human multiple myelomasBlood, 2000
- Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription FactorCell, 1999
- Regulation of Cell Death Protease Caspase-9 by PhosphorylationScience, 1998
- The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-TrisphosphateJournal of Biological Chemistry, 1998
- Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death MachineryCell, 1997
- Signalling through the lipid products of phosphoinositide-3-OH kinaseNature, 1997
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995